Critical components for developing & managing expansive, high-performing collection networks
Streaming from: March 14, 2019
Designing GMP-friendly cell and gene therapy manufacturing processes
Streaming from: March 6, 2019
Managing Starting Material Stability to Maximize Manufacturing Flexibility & Downstream Efficiency
Published: February 21, 2019
Cell therapy startup Mogrify raises 3.7 million USD in seed funding
Published: February 21, 2019
Cell Therapy Quality/CMC & Analytics – Full Spotlight
Published: February 21, 2019
DMD mice sustain dystrophin expression one year after AAV-CRISPR therapy
Published: February 20, 2019
Gene therapy for Sanfilippo A: Lysogene doses first patient in the Phase 2/3 trial
Published: February 19, 2019
Critical considerations & common mistakes in early-phase CMC development
Published: February 18, 2019
Engineered gene therapy reduces seizures in epileptic rat models
Published: February 18, 2019
Non-Viral Vector Mediated Gene Delivery: the Outsider to Watch Out For in Gene Therapy
Published: February 18, 2019
European regulator’s perspective: best practice & future directions in cell therapy CMC
Published: February 15, 2019
Next steps in MSC cell therapy characterization
Published: February 15, 2019
Optimizing quality & compliance for cord blood-derived cells
Published: February 15, 2019
Standards Landscape in Cell Counting: Implications for Cell & Gene Therapy
Published: February 15, 2019
Vor Biopharma raises $42 million to advance engineered HSC technologies
Published: February 15, 2019
Using Machine Learning for Critical Quality Attribute Discovery in Cell Therapy Manufacture
Published: February 14, 2019
An Academic Model for Cell & Gene Therapy Asset Development
Published: February 14, 2019
How to Reduce the Vein to Vein Timeframe Through Efficient, Accelerated QC & Release Testing
Published: February 14, 2019